Martin Norin, Coo
oncology
Kancera
Sweden
Biography
Martin Norin, COO was born in 1959. Ph.D. in biochemistry and M.Sc. in chemistry from the KTH Royal Institute of Technology in Stockholm. Norin has long experience of working in pharmaceutical research. Among other things, he has been a project manager and member of the committee for pharmaceutical development in the preclinical phase at Pharmacia and Biovitrum. Along with Thomas Olin, he led the spin-off of iNovacia from Biovitrum in 2006. As the person in charge of chemistry at Biovitrum AB, Norin was responsible for more than 70 scientists.
Research Interest
As the person in charge of chemistry at Biovitrum AB, Norin was responsible for more than 70 scientists.
